Latest period
$582.00M
YoY change
-5.2%
5Y CAGR
+6.5%
Peak year (2023)
$732.00M
Cumulative CapEx
$6.00B
CapEx history chart for Zoetis (ZTS) from 2009 to 2025
Latest: $621.00M
CapEx growth chart for Zoetis (ZTS) from 2009 to 2025
Latest: -5.2%
CapEx history table for Zoetis (ZTS) from 2009 to 2025
| 2025 | $621.00M | -5.2% | −$34.00M | ||
| 2024 | $655.00M | -10.5% | −$77.00M | ||
| 2023 | $732.00M | +24.9% | +$146.00M | ||
| 2022 | $586.00M | +22.9% | +$109.00M | ||
| 2021 | $477.00M | +5.3% | +$24.00M | ||
| 2020 | $453.00M | -1.5% | −$7.00M | ||
| 2019 | $460.00M | +36.1% | +$122.00M | ||
| 2018 | $338.00M | +50.9% | +$114.00M | ||
| 2017 | $224.00M | +3.7% | +$8.00M | ||
| 2016 | $216.00M | -3.6% | −$8.00M | ||
| 2015 | $224.00M | +14.9% | +$29.00M | ||
| 2014 | $195.00M | +6.0% | +$11.00M | ||
| 2013 | $184.00M | +46.0% | +$58.00M | ||
| 2012 | $126.00M | -6.7% | −$9.00M | ||
| 2011 | $135.00M | +8.9% | +$11.00M | ||
| 2010 | $124.00M | -8.1% | −$11.00M | ||
| 2009 | $135.00M | — | — |
- 2025$621.00M-5.2%
- 2024$655.00M-10.5%
- 2023$732.00M+24.9%
- 2022$586.00M+22.9%
- 2021$477.00M+5.3%
- 2020$453.00M-1.5%
- 2019$460.00M+36.1%
- 2018$338.00M+50.9%
- 2017$224.00M+3.7%
- 2016$216.00M-3.6%
- 2015$224.00M+14.9%
- 2014$195.00M+6.0%
- 2013$184.00M+46.0%
- 2012$126.00M-6.7%
- 2011$135.00M+8.9%
- 2010$124.00M-8.1%
- 2009$135.00M—
CapEx values are taken from Zoetis's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About CapEx at Zoetis (ZTS)
According to Zoetis's latest reported financial statements, the company's current CapEx (TTM) is $582.00M. Capital expenditures (CapEx) are cash outlays for property, plant, and equipment and other long-lived productive assets — reported on the cash flow statement under investing activities. CapEx funds future capacity (factories, data centers, software, machinery), so rising spend can signal investment in growth, while heavy CapEx reduces free cash flow available to shareholders. We display CapEx as a positive amount (the absolute cash outflow); compare with revenue to gauge capital intensity and with total assets for the asset-base context.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Zoetis (ZTS) most recent annual CapEx stands at $621.00M (2025) – declined 5.2% year-over-year.
Over 2020–2025 (5 years), Zoetis CapEx expanded at a +6.5% compound annual rate, with mixed annual results across the window.
Zoetis CapEx peaked at $732.00M in 2023; the latest annual figure is $621.00M in 2025 (15.2% below peak).
Across the available history, CapEx reached its high of $732.00M in 2023 and its low of $124.00M in 2010.
Zoetis Capital Expenditures by Year
Zoetis Capital Expenditures 2025: $621.00M
Zoetis CapEx in 2025 was $621.00M, declined 5.2% below 2024.
Zoetis Capital Expenditures 2024: $655.00M
2024's CapEx for Zoetis came in at $655.00M, declined 10.5% below 2023.
Zoetis Capital Expenditures 2023: $732.00M
Zoetis posted CapEx of $732.00M in 2023, grew 24.9% from 2022. This figure represents the highest annual value in the available history.
Zoetis Capital Expenditures 2022: $586.00M
In 2022, Zoetis reported CapEx of $586.00M, grew 22.9% from 2021.
Zoetis Capital Expenditures 2021: $477.00M
Zoetis CapEx in 2021 was $477.00M.
See more financial history for Zoetis (ZTS).
Sector peers by CapEx
Healthcare peers of Zoetis (ZTS), ranked by their latest CapEx
| $14.05B | |
| $7.84B | |
| $4.83B | |
| $4.11B | |
| $3.62B | |
| $2.81B | |
| $1.86B | |
| $1.21B |
- $14.05B
- $7.84B
- $4.83B
- $4.11B
- $3.62B
- $2.81B
- $1.86B
- $1.21B
Frequently asked questions
Zoetis (ZTS) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation